Trial Profile
Prospective, double-blind, randomized study of safety and efficacy of abobotulinum A (AboBTXA) in women with interstitial cystitis/bladder pain syndrome (IC/BPS)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2015
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Interstitial cystitis
- Focus Therapeutic Use
- 05 Nov 2015 New trial record